Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Theseus Pharmaceuticals stock

Learn how to easily invest in Theseus Pharmaceuticals stock.

Cancer therapies developer Theseus Pharmaceuticals wrapped its initial public offering Thursday, selling 10 million shares at $16 each, the high end of its proposed range. The stock will debut on the Nasdaq later today under the ticker symbol THRX, but shares are available for limit orders at Robinhood and other platforms.

How to buy shares in Theseus Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – THRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Theseus Pharmaceuticals stock price (NASDAQ: THRX)

Use our graph to track the performance of THRX stocks over time.

Theseus Pharmaceuticals shares at a glance

Information last updated 2022-06-30.
Latest market close$5.70
52-week range$4.86 - $24.54
50-day moving average $7.24
200-day moving average $11.34
Wall St. target price$21.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.76

Buy Theseus Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Theseus Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Theseus Pharmaceuticals price performance over time

Historical closes compared with the close of $5.7 from 2022-07-01

1 week (2022-06-24) -5.32%
1 month (2022-06-03) -5.16%
3 months (2022-04-04) -55.98%
6 months (2022-01-04) -48.23%
1 year (2021-06-30) N/A
2 years (2020-06-30) N/A
3 years (2019-06-30) N/A
5 years (2017-06-30) N/A

Theseus Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -11.95%
Return on equity TTM -27.22%
Profit margin 0%
Book value $6.27
Market capitalisation $201.3 million

TTM: trailing 12 months

Theseus Pharmaceuticals share dividends

We're not expecting Theseus Pharmaceuticals to pay a dividend over the next 12 months.

Theseus Pharmaceuticals overview

Theseus Pharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. .

Frequently asked questions

What percentage of Theseus Pharmaceuticals is owned by insiders or institutions?
Currently 3.572% of Theseus Pharmaceuticals shares are held by insiders and 91.877% by institutions.
How many people work for Theseus Pharmaceuticals?
Latest data suggests 26 work at Theseus Pharmaceuticals.
When does the fiscal year end for Theseus Pharmaceuticals?
Theseus Pharmaceuticals's fiscal year ends in December.
Where is Theseus Pharmaceuticals based?
Theseus Pharmaceuticals's address is: 245 Main Street, Cambridge, MA, United States, 02142
What is Theseus Pharmaceuticals's ISIN number?
Theseus Pharmaceuticals's international securities identification number is: US88369M1018

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site